R&D consulting | Pharma Biotech
OUR EXPERTISE
FOR
YOUR INNOVATION
R&D strategy and preclinical development support for biotech and medtech innovators.
​
BE4S helps biotech, medtech and academic spin-off projects structure their R&D programs, prepare investor-ready scientific packages, select CRO/CDMO partners and accelerate the path toward clinical development.
Who we support
Biotech start-ups, medtech companies, academic spin-offs, technology transfer offices, pharma R&D teams and investors evaluating life science assets.
Biotech & medtech
Start-ups and innovators turning early science into structured development program.
Academic spin-offs
TTOs and founders preparing investor, partner or translational milestones.
Investors & pharma
Teams evaluating scientific assets, risks and development readiness.
Why BE4S
​
25+ years R&D experience
​
7+ years in consultancy
28+ scientific publications
IMPD dossier writing
20+ years pharma industry
​
5+ years CDMO
12 patents as inventor
EMA interactions
Positioning: senior R&D strategy partner, not a generic expert directory.
Core Services
BE4S provides strategic and operational R&D support to help biotech, medtech and pharma teams move from scientific evidence to development readiness. Our core services include R&D diagnostics, preclinical roadmaps, investor-ready scientific packages, CRO/CDMO selection, quality and documentation support, and expert guidance across drug design, bioproduction, CMC and characterization.
Engagement models
BE4S offers flexible engagement models tailored to each project’s stage, priorities and internal resources. Support can range from a focused strategic diagnostic or a defined project assignment to ongoing fractional R&D leadership, expert coordination and milestone reviews.
Trust proof
BE4S combines senior pharma R&D experience, biotherapeutics expertise and hands-on exposure to regulatory documentation, first-in-human programs and external partner management. This experience is supported by scientific publications, patents and a network of specialist experts across the development chain.
Selected expertise
BE4S provides access to selected expertise across key stages of the development process, including drug design, preclinical strategy, bioproduction, CMC, biomolecule characterization, quality, regulatory documentation and partner coordination. This multidisciplinary approach helps teams address complex scientific and operational challenges with the right level of specialist support.